Alexander Menter

Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

Shaji Kumar, Susanna Jacobus, Adam D. Cohen et al. · The Lancet Oncology · 2020 · 253 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen et al. · Communications Medicine · 2023 · 32 citations · Full text

Medicine, Immunology, Oncology +17

A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid Tumors

Samir E. Witta, Daniel L. Gustafson, A. Scott Pierson et al. · Clinical Cancer Research · 2004 · 24 citations

Medicine, Oncology, Pharmacology +14

Results of a phase III randomized, controlled study evaluating the efficacy and safety of idelalisib (IDELA) in combination with ofatumumab (OFA) for previously treated chronic lymphocytic leukemia (CLL).

Jeffrey A. Jones, Tadeusz Robak, Jennifer R. Brown et al. · Journal of Clinical Oncology · 2015 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +15

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data

Gabriel A. Brooks, Hajime Uno, Erin J. Aiello Bowles et al. · JCO Clinical Cancer Informatics · 2019 · 20 citations

Medicine, Oncology, Cancer Epidemiology +14